Back to Mesalazine

Mesalazine Uses in Pakistan

Mesalazine (mesalazine / 5-aminosalicylic acid) is a commonly prescribed bowel anti-inflammatory in Pakistan. This guide covers all its approved uses, indications, and important information you should know.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated:

Uses

Quick Answer

Mesalazine (5-aminosalicylic acid) is used to induce and maintain remission in ulcerative colitis and to manage Crohn's disease. It belongs to the aminosalicylate class. It is available in Pakistan. Always take it at the correct dose as directed by your doctor or pharmacist.

Primary Uses at a Glance

Induction and Maintenance of Remission in Ulcerative Colitis

Mesalazine (mesalazine) is used to induce remission in active ulcerative colitis and to maintain remission once achieved. This is the primary approved indication for mesalazine in Pakistan.

As prescribed by your gastroenterologist. Dose depends on severity.

Management of Crohn's Disease

Mesalazine (mesalazine) is used in the management of Crohn's disease, particularly for mild to moderate colonic involvement. This is one of the primary approved indications in Pakistan.

As prescribed by your gastroenterologist under specialist supervision.

Prevention of Colorectal Cancer Risk in Long-Term IBD

Mesalazine (mesalazine) is used for long-term prevention of colorectal cancer risk in patients with chronic inflammatory bowel disease. This is one of the recognised uses of mesalazine.

As prescribed by your gastroenterologist for long-term maintenance.

Other Uses

  • Microscopic colitis (under specialist supervision)
  • Pouchitis following colectomy (under specialist guidance)

Mesalazine Uses (Fayde / Kis kaam aati hai)

Mesalazine contains mesalazine (5-aminosalicylic acid) and belongs to the Aminosalicylate group. Below are all the approved and common uses of Mesalazine in Pakistan.

Primary Uses (Mukhya Istemal)

  • Induction and maintenance of remission in ulcerative colitis
  • Management of Crohn's disease
  • Prevention of colorectal cancer risk in long-term inflammatory bowel disease

Who Should Take It (Kin logon ke liye)

  • Patients with mild to moderate active ulcerative colitis
  • Patients in remission from ulcerative colitis requiring maintenance therapy
  • Patients with Crohn's disease under specialist supervision

When NOT to Use Mesalazine (Kab nahi leni chahiye)

  • If you are allergic to mesalazine, salicylates, or sulphasalazine
  • If you have severe kidney disease
  • If you have severe liver disease

Summary

Mesalazine is prescribed for ulcerative colitis (remission induction and maintenance) and Crohn's disease management. Always consult a doctor before starting or stopping this medicine.

The information in this guide is for educational purposes only.

Frequently Asked Questions

For which conditions is Mesalazine most effective?

Mesalazine is most effective for mild to moderate ulcerative colitis, both for inducing and maintaining remission. Always take it for the condition your doctor has prescribed it for.

Can Mesalazine be taken without a doctor's prescription?

Mesalazine is a prescription medicine. Do not take it without a doctor's advice. Regular kidney function monitoring is required during treatment.

How long does Mesalazine take to show results?

Mesalazine may take several weeks to show its full effect. Follow your doctor's advice on how long to continue the course without stopping early.

Can Mesalazine be taken long-term?

Long-term use of Mesalazine is common for maintenance of remission in ulcerative colitis. It should only be done under medical supervision with periodic kidney function monitoring.

What should I do if Mesalazine does not seem to work?

If symptoms are not improving, do not increase the dose on your own. Consult your doctor to review the diagnosis and treatment plan.

Brand alternatives, same-class options, and other medicines used for the same conditions as Mesalazine.

Sources

  1. DRAP Registered Products Database Drug Regulatory Authority of Pakistan
  2. WHO Model List of Essential Medicines, 23rd ed. (2023) World Health Organization
  3. British National Formulary (BNF) BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.